Fierce Health Technology March 11, 2020
Paige Minemyer

Blue Shield of California will cover rapid whole genome sequencing for children with unexplained medication conditions, becoming the first health plan in the country to do so.

Rady Children’s Institute for Genomic Medicine researchers have developed a method of genome sequencing that takes less than three days, getting the results more quickly into the hands of doctors treating children who are critically ill.

Terry Gilliland, M.D., executive vice president of healthcare quality and affordability at Blue Shield, told FierceHealthcare there are a number of access barriers patients and their families can face if they need such testing, including cost and a potentially lengthy wait for prior authorization processing.

“We really go out in front of this one,”...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Payer, Precision Medicine, Provider, Technology
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article